Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://zaynabhmvr822587.wikidirective.com/8603628/this_new_drug_retatrutide_australia_a_new_breakthrough_for_weight_management